Molecular biology and genetics in cardiovascular research: highlights of 2002VAN ZONNEVELD, A. J.Netherlands journal of medicine. 2003, Vol 61, Num 5, pp 28-34, issn 0300-2977, 7 p., SUPConference Paper

Autonomous functions of structural domains on human tissue-type plasminogen activatorVAN ZONNEVELD, A.-J; VEERMAN, H; PANNEKOEK, H et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 13, pp 4670-4674, issn 0027-8424Article

On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin: inhibition of kringle-2 binding to fibrin by ε-amino caproic acidVAN ZONNEVELD, A.-J; VEERMAN, H; PANNEKOEK, H et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 30, pp 14214-14218, issn 0021-9258Article

The mechanism and regulation of the fibrinolytic systemVAN MOURIK, J. A; VAN ZONNEVELD, A.-J; PANNEKOEK, H et al.Developments in hematology and immunology. 1989, Vol 23, pp 115-125, issn 0167-9201Article

Functional analysis of the human tissue-type plasminogen activator protein: the light chainMACDONALD, M. E; VAN ZONNEVELD, A.-J; PANNEKOEK, H et al.Gene (Amsterdam). 1986, Vol 42, Num 1, pp 59-67, issn 0378-1119Article

Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cellsKUIPER, J; OTTER, M; VOORSCHUUR, A. H et al.Thrombosis and haemostasis. 1995, Vol 74, Num 5, pp 1298-1304, issn 0340-6245Article

Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expressionLOOMANS, C. J. M; WAN, H; DE CROM, R et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 8, pp 1760-1767, issn 1079-5642, 8 p.Article

Free radical production by dysfunctional eNOS : Free radicals and redox signalling in cardiovascular diseaseVERHAAR, M. C; WESTERWEEL, P. E; VAN ZONNEVELD, A. J et al.Heart (London 1996). 2004, Vol 90, Num 5, pp 494-495, issn 1355-6037, 2 p.Article

Functional display of proteins, mutant proteins, fragments of proteins and peptides on the surface of filamentous (bacterio) phages : a reviewPANNEKOEK, H; VAN MEIJER, M; GAARDSVOLL, H et al.Cytotechnology (Dordrecht). 1995, Vol 18, Num 1-2, pp 107-112, issn 0920-9069Article

Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosisVON DER THÜSEN, Jan H; FEKKES, Madelon L; PASSIER, Robert et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 2, pp 357-362, issn 1079-5642, 6 p.Article

Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbitsFRIEDERICH, P. W; LEVI, M; BIEMOND, B. J et al.Circulation (New York, N.Y.). 1997, Vol 96, Num 3, pp 916-921, issn 0009-7322Article

Microvascular Damage in Type 1 Diabetic Patients Is Reversed in the First Year After Simultaneous Pancreas―Kidney TransplantationKHAIROUN, M; DE KONING, E. J. R; DE FIJTER, J. W et al.American journal of transplantation (Print). 2013, Vol 13, Num 5, pp 1272-1281, issn 1600-6135, 10 p.Article

Human CD34⁺/KDR⁺ Cells Are Generated From Circulating CD34⁺ Cells After Immobilization on Activated PlateletsDE BOER, H. C; HOVENS, M. M; VAN OEVEREN-RIETDIJK, A. M et al.Arteriosclerosis, thrombosis, and vascular biology. 2011, Vol 31, Num 2, pp 408-415, issn 1079-5642, 8 p.Article

Progenitor cells in the kidney: Biology and therapeutic perspectivesROOKMAAKER, Maarten B; VERHAAR, M. C; VAN ZONNEVELD, A. J et al.Kidney international. 2004, Vol 66, Num 2, pp 518-522, issn 0085-2538, 5 p.Conference Paper

Structural domains of human tissue-type plasminogen activator that confer stimulation by heparinSTEIN, P. L; VAN ZONNEVELD, A.-J; PANNEKOEK, H et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 26, pp 15441-15444, issn 0021-9258, 4 p.Article

MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammationASGEIRSDOTTIR, S. A; VAN SOLINGEN, C; KAMPS, J. A. A. M et al.American journal of physiology. Renal physiology. 2012, Vol 71, Num 6, issn 1931-857X, F1630-F1639Article

Inflammation, vascular injury and repair in rheumatoid arthritisVAN ZONNEVELD, A. J; DE BOER, H. C; VAN DER VEER, E. P et al.Annals of the rheumatic diseases. 2010, Vol 69, issn 0003-4967, i57-i60, SUP1Article

Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotypeDE BOER, H. C; VERSEYDEN, C; ULFMAN, L. H et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 7, pp 1653-1659, issn 1079-5642, 7 p.Article

Vascular endothelial genes that are responsive to tumor necrosis factor-α in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genesHORREVOETS, A. J. G; FONTIJN, R. D; VAN ZONNEVELD, A. J et al.Blood. 1999, Vol 93, Num 10, pp 3418-3431, issn 0006-4971Article

Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor βKEETON, M. R; CURRIDEN, S. A; VAN ZONNEVELD, A.-J et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 34, pp 23048-23052, issn 0021-9258Article

Activation of human factor V by meizothrombinTANS, G; NICOLAES, G. A. F; THOMASSEN, M. C. L. G. D et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 23, pp 15969-15972, issn 0021-9258Article

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene familyPANNEKOEK, H; VEERMAN, H; LAMBERS, H et al.EMBO journal (Print). 1986, Vol 5, Num 10, pp 2539-2544, issn 0261-4189Article

The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activatorVAN MEIJER, M; STOOP, A; SMILDE, A et al.Thrombosis and haemostasis. 1997, Vol 77, Num 3, pp 516-521, issn 0340-6245Article

Thrombin-variable region 1 (VR1) : evidence for the dominant contribution of VR1 of serine proteases to their interaction with plasminogen activator inhibitor 1HORREVOETS, A. J. G; TANS, G; SMILDE, A. E et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 2, pp 779-782, issn 0021-9258Article

Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activatorHORN, I. R; VAN DEN BERG, B. M. M; MOESTRUP, S. K et al.Thrombosis and haemostasis. 1998, Vol 80, Num 5, pp 822-828, issn 0340-6245Article